Operating Margin

SDEV reported a massive Q1 profit, but the real story is its unique strategy as a public DeFi holding company and the complex accounting behind the numbers.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

Hyster launches the XTLG series, blending a rugged ICE chassis with lithium-ion power to bring electric efficiency to demanding outdoor applications.

With revenue hitting a record $47.6M, TerraCycle proves sustainability is profitable. But as it raises millions, can it overcome greenwashing critiques?

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

Newly public Yesway faces its first major test with its Q1 earnings. Investors will scrutinize if its aggressive expansion can meet high analyst expectations.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Chinese machinery giant XCMG deepens its Belt and Road presence, betting that high-performance electric equipment will drive a value-based green shift.

Wall Financial renews its significant share buyback plan, signaling confidence. But does it mask deeper concerns about debt and a volatile real estate market?

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

The footwear giant exceeded Q1 expectations, boosting its full-year profit outlook on the back of double-digit growth from its star athletic brands.

The 2026 Chandler Index reveals a paradox: government performance is up, but a staggering 70% of nations are fiscally weaker than five years ago.

As the space economy booms, a top TMT research firm launches dedicated coverage, signaling a new era of financial scrutiny for giants like SpaceX and Rocket Lab.

A new report reveals a record 4,434 satellites launched in 2025, as the industry's revenue soars and U.S. innovation solidifies its global dominance.

Global luxury leaders meet in Milan to tackle margin pressures, a new world map for growth, and the disruptive power of artificial intelligence.

The nation's largest EMS provider, GMR Solutions, saw its stock surge on its NYSE debut after a major IPO price cut to appease wary investors.

JBS posts a $221M profit despite a major loss in its US beef unit, showcasing the power of its diversified global strategy in volatile markets.

The industrial giant affirms its quarterly payout, a sign of stability for investors as it navigates a costly green transition and recent regulatory hurdles.